Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui Ping Zhao

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 28, 2005
[Differentiation from human embryonic stem cells to hematopoietic cells and endothelial cells]Jian Wang, Hui-Ping Zhao, Chang-Qing Xie, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 6, 2014
Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional studyJie Dong, Qin Wang, Meng-Hua Chen, et al.
European Journal of Pharmacology|January 30, 2024
NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagyHui-Ping Zhao, Yuan Ma, Xiao-Juan Zhang, et al.
British Journal of Pharmacology|February 11, 2026
The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin-induced cardiomyopathyJing Wang, Chen-Mo-Zhen Li, Bin Yang, et al.
Toxicology and Applied Pharmacology|February 10, 2023
GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stressXiao-Juan Zhang, Lu Li, Ai-Ling Wang, et al.
European Journal of Pharmacology|June 18, 2021
Sphingosine-1-phosphate induces myocyte autophagy after myocardial infarction through mTOR inhibitionLi-Guo Yang, Ai-Ling Wang, Lu Li, et al.
Plos One|December 11, 2012
Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort studyRong Xu, Qing-Feng Han, Tong-Ying Zhu, et al.
Plos One|January 14, 2014
The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patientsJie Dong, Qing-Feng Han, Tong-Ying Zhu, et al.
Plos One|May 7, 2014
The associations between the family education and mortality of patients on peritoneal dialysisZhi-Kai Yang, Qing-Feng Han, Tong-Ying Zhu, et al.
British Journal of Pharmacology|March 10, 2025
SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokinesHong-Xia Guo, Run-Nan Tantai, Bin Yang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 28, 2005
[Differentiation from human embryonic stem cells to hematopoietic cells and endothelial cells]Jian Wang, Hui-Ping Zhao, Chang-Qing Xie, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 6, 2014
Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional studyJie Dong, Qin Wang, Meng-Hua Chen, et al.
European Journal of Pharmacology|January 30, 2024
NADPH oxidase 2 inhibitor GSK2795039 prevents doxorubicin-induced cardiac atrophy by attenuating cardiac sympathetic nerve terminal abnormalities and myocyte autophagyHui-Ping Zhao, Yuan Ma, Xiao-Juan Zhang, et al.
British Journal of Pharmacology|February 11, 2026
The NADPH oxidase inhibitor Vas2870 prevents myocyte ferroptosis and improves cardiac remodelling and function in doxorubicin-induced cardiomyopathyJing Wang, Chen-Mo-Zhen Li, Bin Yang, et al.
Toxicology and Applied Pharmacology|February 10, 2023
GSK2795039 prevents RIP1-RIP3-MLKL-mediated cardiomyocyte necroptosis in doxorubicin-induced heart failure through inhibition of NADPH oxidase-derived oxidative stressXiao-Juan Zhang, Lu Li, Ai-Ling Wang, et al.
European Journal of Pharmacology|June 18, 2021
Sphingosine-1-phosphate induces myocyte autophagy after myocardial infarction through mTOR inhibitionLi-Guo Yang, Ai-Ling Wang, Lu Li, et al.
Plos One|December 11, 2012
Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort studyRong Xu, Qing-Feng Han, Tong-Ying Zhu, et al.
Plos One|January 14, 2014
The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patientsJie Dong, Qing-Feng Han, Tong-Ying Zhu, et al.
Plos One|May 7, 2014
The associations between the family education and mortality of patients on peritoneal dialysisZhi-Kai Yang, Qing-Feng Han, Tong-Ying Zhu, et al.
British Journal of Pharmacology|March 10, 2025
SEW2871 attenuates myocyte necroptosis in heart failure through inhibition of oxidative stress and inflammatory cytokinesHong-Xia Guo, Run-Nan Tantai, Bin Yang, et al.
Pageof 4